Preliminary figures for the first quarter indicate strong growth for Nexam Chemical and extends the subscription period in the ongoing rights issue
Nexam Chemical experienced a strong development during the first quarter and sales are expected to amount to approximately SEK 40 million (SEK 31.7 million), which is the strongest quarter in the company's history. EBITDA is estimated to amount to about SEK 2 million (SEK -1.7 million). Following the announcement of the quarterly result, Nexam Chemical extends the subscription period in the ongoing rights issue until Thursday, April 2, 2020.Sales of SEK 40 million correspond to a growth of 26 percent, which is mainly driven by continued strong development within the business area